Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan + amlodipine versus losartan + hydrochlorothiazide for regression of left ventricular hypertrophy in mild-to-moderate hypertension
2006-001977-17Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in hypertension (HTN) comparing Valsartan + amlodipine with Losartan + hydrochlorothiazide (2 arms). Primary endpoint: Change from baseline in left ventricular mass index. Started Jul 2006; status: completed.
02
Drugs
valsartanamlodipinelosartanhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2006-001977-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001977-17.